DATAGROUP SE

  • WKN: A0JC8S
  • ISIN: DE000A0JC8S7
  • Land: Deutschland

Nachricht vom 16.08.2019 | 10:08

DATAGROUP SE: DATAGROUP entered into a contract to acquire assets and corporate divisions of insolvent IT Informatik GmbH

DATAGROUP SE / Key word(s): Takeover
DATAGROUP SE: DATAGROUP entered into a contract to acquire assets and corporate divisions of insolvent IT Informatik GmbH

16-Aug-2019 / 10:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


DATAGROUP entered into a contract to acquire assets and corporate divisions of insolvent IT Informatik GmbH
 

Pliezhausen, August 16, 2019. DATAGROUP SE (WKN A0JC8S).

With retroactive effect from August 01, 2019, DATAGROUP acquires 100 % of the shares in Mercoline GmbH, 100 % of the shares in IT Digitalizacion 4.0 Industrial Internacional S.L. as well as employees and assets of IT Informatik GmbH. The parties have agreed not to disclose the purchase price.

Founded in Ulm in 1987, IT Informatik GmbH is specialized in SAP consulting and maintenance, cloud infrastructure as well as software development and supplies a broad portfolio of SME customers of different industries. In May 2019, the company filed an application for restructuring under its own management. DATAGROUP intends to continue business operations in Ulm, Berlin and Barcelona.

NOTIFYING PERSON:

Max H.-H. Schaber,
Chief Executive Officer of DATAGROUP SE,
Wilhelm-Schickard-Str. 7
72124 Pliezhausen

CONTACT FOR FURTHER INFORMATION

DATAGROUP SE
Claudia Erning
Wilhelm-Schickard-Str. 7
72124 Pliezhausen

T +49 7127 970-015
F +49 7127 970-033
claudia.erning@datagroup.de



 

16-Aug-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

Aktuelle Research-Studie

OpenLimit Holding AG

Original-Research: OpenLimit Holding AG (von First Berlin Equity Research GmbH): Buy

14. Oktober 2019